Sign up to save tools and stay up to date with the latest in AI
bg
bg
1

Medeloop Secures $15.5 Million in Series A Funding to Accelerate Medical Research

Nov 13, 2024 - financialpost.com
Medeloop, a medical research platform, has secured $15.5 million in a Series A funding round to accelerate its research. The round was led by Inovia Capital and included contributions from Icon Ventures, General Catalyst, Maven Ventures, Healthier Capital, Up2 Opportunity Fund, and CFO Advisors. Medeloop's platform uses AI to streamline research processes, making it faster and more accessible to individual researchers and smaller institutions. The platform can perform analyses up to 1,000 times faster than traditional methods, which could lead to significant breakthroughs in medical research.

With the new funding, Medeloop plans to expand its AI-powered platform, which simplifies the complexities of medical research. The platform includes a grant platform, a dual-component studies platform, a no-code analytics platform, and a manuscript publication platform. Medeloop's mission is to revolutionize healthcare research and improve patient outcomes.

Key takeaways:

  • Medeloop, a medical research platform, has secured $15.5 million in Series A funding led by Inovia Capital and supported by Icon Ventures, General Catalyst, Maven Ventures, Healthier Capital, Up2 Opportunity Fund, and CFO Advisors.
  • The platform uses autonomous AI agents to streamline research processes, enabling faster and more accessible research.
  • Medeloop plans to expand its AI-powered platform, which simplifies medical research and includes a grant platform, a studies platform, a no-code analytics platform, and a manuscript publication platform.
  • Medeloop was founded with the mission to find a cure for Complex Regional Pain Syndrome (CRPS) and aims to revolutionize healthcare research and improve patient outcomes.
View Full Article

Comments (0)

Be the first to comment!